The total return over the past 12 months is -85.66% vs. +16.94% for the S&P 500. So far it's up -75.64% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (85.66%) | (61.02%) | (53.69%) | N/A | N/A | N/A |
| Total Return CAGR | (85.66%) | (61.02%) | (53.69%) | N/A | N/A | N/A |
| Revenue CAGR | (86.76%) | (69.10%) | (56.28%) | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
CollPlant Biotechnologies Ltd. (CLGN)
| Year | Start price | End price | CLGN Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $14.00 | $3.41 | (75.64%) | +14.51% | (90.15%) |
| 2025 | $36.00 | $14.00 | (61.11%) | +17.72% | (78.83%) |
| 2024 | $63.90 | $36.00 | (43.66%) | +24.89% | (68.55%) |
| 2023 | $83.50 | $63.90 | (23.47%) | +26.19% | (49.66%) |
| 2022 | $163.60 | $83.50 | (48.96%) | (18.17%) | (30.79%) |
| 2021 | $107.70 | $163.60 | +51.90% | +28.74% | +23.16% |
| 2020 | $57.00 | $107.70 | +88.95% | +18.37% | +70.58% |
| 2019 | $42.00 | $57.00 | +35.71% | +31.22% | +4.49% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
